Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

July 24, 2007 Approval Letter - Fluvirin

Our STN: BL 103837/5240

July 24, 2007

Novartis Vaccines and Diagnostics Limited
Attn: Ms. Lisa Bissett
Gaskill Road, Speke
Liverpool L24 9GR
United Kingdom

Dear Ms. Bissett:

We have approved your request to supplement your biologics license application for Influenza Virus Vaccine, Fluvirin®, to include the 2007-2008 United States formulation. We will include information contained in the above-referenced supplement in your biologics license application file.

Please submit four copies of final printed labeling at the time of use with completed implementation information.

Sincerely yours,

--- signature ---

Jerry Weir, Ph.D.
Division of Viral Products
Office of Vaccines Research and Review
Center for Biologics Evaluation and Research

Attachment: Final Draft Labeling of Package Insert, Carton, and Container

Return to product page

Page Last Updated: 03/30/2009
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English